“We like to tease that market access is an overnight sensation 20 years in the making. But in all seriousness, market access has always been ultra-important to those of us working in the space, so it’s rewarding to see greater recognition across the industry.” Andrew Gottfried, CEO of Entrée Health, discusses one of the most important and hottest topics in pharma today: market access.
Tag Archive for: health economics
The development is the latest in SCIRIS’ rapid expansion, having over the last two years acquired six agencies with considerable scientific and commercial expertise on both sides of the Atlantic.
Lumanity’s deep data analytics, value demonstration, and therapeutic area expertise alongside HealthVerity’s patient identity resolution technology and leading ecosystem of interoperable real-world data enables evidence generation across the pharma lifecycle.
